(Q30049107)

25 May 2017

0 references

4

Elias Toubi

1 reference

25 May 2017

author name string

Zahava Vadasz

series ordinal

1

1 reference

25 May 2017

Tharwat Haj

series ordinal

2

1 reference

25 May 2017

Aharon Kessel

series ordinal

3

1 reference

25 May 2017

language of work or name

English

0 references

publication date

22 May 2013

1 reference

25 May 2017

1 reference

25 May 2017

volume

587

1 reference

25 May 2017

issue

13

1 reference

25 May 2017

page(s)

2074-2078

1 reference

Effector and regulatory B cells: modulators of CD4+ T cell immunity

25 May 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

B cells regulate autoimmunity by provision of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.023

10.1016/J.FEBSLET.2013.05.023

21 January 2018

Identifiers

DOI

1 reference